EPs and EHs may use the following list as guidance for preparing and submitting immunization data to USIIS for the purpose of meeting the Public Health Reporting objective – Immunization Registry Reporting. To meet this measure EPs and EHs must be in ‘active engagement’ with USIIS to submit immunization data.
Use the following button to access the online form to register your intent to submit ongoing electronic immunization data to USIIS for Meaningful Use. Note: this form requires the EP or EH to cite their intent to report data related to all public health reporting objectives.
Important Note – As the Meaningful Use contact for the locations you registered, you are required to acknowledge and respond to Meaningful Use communications from USIIS within 30 days. Failure to do so on two separate occasions will result in failing to meet the Public Health Reporting objective – Immunization Registry reporting measure.
After USIIS – and the other Utah Department of Health public health programs – receive your online registration, the “Meaningful Use Contact Person” entered on the registration form will be contacted and given further information regarding next steps.
The “Meaningful Use Contact Person” entered on the registration form will be the point of contact for all communications for USIIS. Please make sure this person is ready to respond to important Meaningful Use communications – which may be via phone or email.
Upon submission, your online registration will be placed into queue. Testing priority may be based upon the order in which online registrations are received.
If the certified EHR system in use at your location(s) has not already developed and tested an HL7 interface with USIIS, your MU Contact Person will be notified.
The EP or EH must contact their EHR vendor and request the vendor develop and test an HL7 version 2.5.1 immunization interface to USIIS. Note: Stage 3 requires Bi-directional exchange using HL7 2.5.1 Release 1.5 and Release 1.5 Addendum.
EHR vendors will be expected to:
To receive a confirmation memo documenting status of Meaningful Use, please contact USIIS.
If you have questions regarding the USIIS on-boarding process, please contact:
Jyl Bosone, USIIS Senior Business Analyst